U.S. flag

An official website of the United States government

Medicaid State Plan Amendments

A Medicaid and CHIP state plan is an agreement between a state and the Federal government describing how that state administers its Medicaid and CHIP programs. It gives an assurance that a state will abide by Federal rules and may claim Federal matching funds for its program activities. The state plan sets out groups of individuals to be covered, services to be provided, methodologies for providers to be reimbursed and the administrative activities that are underway in the state.

When a state is planning to make a change to its program policies or operational approach, states send state plan amendments (SPAs) to the Centers for Medicare & Medicaid Services (CMS) for review and approval. States also submit SPAs to request permissible program changes, make corrections, or update their Medicaid or CHIP state plan with new information.

Persons with disabilities having problems accessing the SPA PDF files may call 410-786-0429 for assistance.

Results

Displaying 3601 - 3610 of 15690

West Virginia
CMS is approving this time-limited state plan amendment to respond to the COVID-19 national emergency.  The purpose of this amendment is to increase payments for personal care services, private duty nursing, and behavioral health services using American Rescue Plan Act Section 9817 funds.  The rate increases for personal care services are effective from 4/1/2021-3/31/2022, and the rate increases for private duty nursing and behavioral health services are effective from 7/1/2021-3/31/2022.  This SPA also authorizes a payment increase for the administration of in-home COVID-19 vaccinations to beneficiaries who are homebound or otherwise hard-to-reach.
Approval Date: May 6, 2022
Effective Date: April 1, 2021

Hawaii
This amendment adds an assurance of coverage of routine patient services and costs associated with participation in qualifying clinical trials, as required by section 210 of the Consolidated Appropriations Act.
Approval Date: May 6, 2022
Effective Date: January 1, 2022
Topics: Coverage and Reimbursement

New Jersey
This amendment was submitted in order to update the reimbursement methodology for 1915(j) Self-Directed Personal Care Assistance Services.
Approval Date: May 6, 2022
Effective Date: January 1, 2022

Iowa
This amendment assures that Iowa will cover the mandatory benefit for costs of routine services related to participation in clinical trials in the state plan.
Approval Date: May 5, 2022
Effective Date: January 1, 2022

New Hampshire
This amendment proposes to amend the Title XIX State Plan to provide assurance regarding coverage of routine patient costs associated with participation in qualifying clinical trials on or after January 1, 2022.
Approval Date: May 5, 2022
Effective Date: January 1, 2022

Vermont
To add language that details adherence with mandatory coverage of routine patient costs for services furnished in connection with qualifying clinical trials in accordance with the Consolidated Appropriations Act, 2021.
Approval Date: May 5, 2022
Effective Date: January 1, 2022

North Carolina
The Pregnancy Medical Home program will be replaced by the Pregnancy Management Program.
Approval Date: May 5, 2022
Effective Date: July 1, 2022

District of Columbia
To add coverage to the District of Columbia’s Alternative Benefit Plan Medicaid Expansion, Routine Patient Cost in Qualifying Clinical Trials.
Approval Date: May 5, 2022
Effective Date: January 1, 2022

Connecticut
Allows reimbursement changes for private intermediate care facilities for individuals with intellectual disabilities (ICF/IIDs). Specifically, this SPA provides specified fair rent increases and implements a rate increase of 4.3% to pay for costs of wage and benefit enhancements.
Approval Date: May 4, 2022
Effective Date: July 1, 2022
Topics: Financing & Reimbursement

Mississippi
Complies with necessary changes resulting from the Consolidated Appropriations Act, 2021 requiring mandatory coverage of routine patient costs for services furnished in connection with participation by Medicaid beneficiaries in qualifying clinical trials on or after January 1, 2022.
Approval Date: May 4, 2022
Effective Date: January 1, 2022